mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR
about
Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and PerspectivesAMPK-mediated up-regulation of mTORC2 and MCL-1 compromises the anti-cancer effects of aspirin.mTORC2 is a tyrosine kinase.Targeting mTORC2 component rictor inhibits cell proliferation and promotes apoptosis in gastric cancer.mTORC1-independent autophagy regulates receptor tyrosine kinase phosphorylation in colorectal cancer cells via an mTORC2-mediated mechanism.MicroRNA-191, acting via the IRS-1/Akt signaling pathway, is involved in the hepatic insulin resistance induced by cigarette smoke extract.The natural agent rhein induces β-catenin degradation and tumour growth arrest.The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling.Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling.Leishmania proteophosphoglycans regurgitated from infected sand flies accelerate dermal wound repair and exacerbate leishmaniasis via insulin-like growth factor 1-dependent signalling.Mammalian target of rapamycin complex 2 (mTORC2) controls glycolytic gene expression by regulating Histone H3 Lysine 56 acetylation.Expression and Comparison of Cbl-b in Lung Squamous Cell Carcinoma and Adenocarcinoma.The role of RICTOR downstream of receptor tyrosine kinase in cancers.Identification of WDR12 as a novel oncogene involved in hepatocellular carcinoma propagation
P2860
Q28071388-EAA4AD36-8C01-4BFB-ADC9-9D68425C3C83Q37086032-2F2C4B07-EB30-4D28-BD0A-A03DE1B5C423Q39743669-C295035F-508E-4571-8F07-3504013A5CD1Q42068002-338C7BE1-C104-4760-9797-5DC572EB5607Q42509388-C8EAEC23-F9DF-4F42-8907-20731CA42FF8Q43365390-8608251B-4006-4B26-9DA0-6452A5FB10EEQ47112541-5C3625F1-8C91-4530-88A2-6E3ADA98090CQ47119946-5A109C4B-5B22-4FA2-B8C4-0706C3246FD2Q47144046-C738C2A1-CDFE-4692-861F-DCE663D5EEE2Q47551102-7385401D-B7C6-41C2-9D42-E36B67020E6FQ47795010-19F02BCC-9C08-4467-8E7D-A8EEC2D68C3CQ49240447-478824DE-943F-48C5-A768-22BE92836CE6Q49887908-5FCEEDE6-2F7D-4B94-A087-B51367CD8CCCQ57490701-C2836BB9-264F-44A3-9B90-5C88DB3A9AB3
P2860
mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
mTORC2 promotes type I insulin ...... rosine kinase activity of mTOR
@ast
mTORC2 promotes type I insulin ...... rosine kinase activity of mTOR
@en
mTORC2 promotes type I insulin ...... rosine kinase activity of mTOR
@nl
type
label
mTORC2 promotes type I insulin ...... rosine kinase activity of mTOR
@ast
mTORC2 promotes type I insulin ...... rosine kinase activity of mTOR
@en
mTORC2 promotes type I insulin ...... rosine kinase activity of mTOR
@nl
prefLabel
mTORC2 promotes type I insulin ...... rosine kinase activity of mTOR
@ast
mTORC2 promotes type I insulin ...... rosine kinase activity of mTOR
@en
mTORC2 promotes type I insulin ...... rosine kinase activity of mTOR
@nl
P2093
P2860
P3181
P356
P1433
P1476
mTORC2 promotes type I insulin ...... rosine kinase activity of mTOR
@en
P2093
Qingbin Kong
Yangfu Jiang
Yuanming Luo
P2860
P2888
P3181
P356
10.1038/CR.2015.133
P407
P577
2016-01-01T00:00:00Z